Governance is key to controlling SARS-CoV-2's vaccine resistance
Okamoto, K. W.; Chaves, L. F.; Wallace, R.; Wallace, R. G.
Show abstract
Little attention has been paid to governances impacts on the evolution of SARS-CoV-2, the virus that causes COVID-19. To evaluate such impacts on the evolution of vaccine resistance, we analyzed a stochastic compartmental model to quantify the risk a mutant strain capable of evading immunity emerges post-vaccine rollout. We calibrated the model with publicly available data for four territories in the Western Hemisphere qualitatively differing in pandemic interventions. The model shows an immune-evading strain to be readily selected over all infectivities in Texas. In Panama, only a high level of transmission permits immune evasion to evolve. No invasion appears likely in Costa Rica and Uruguay. Programs combining pharmaceutical and nonpharmaceutical interventions are best positioned to remove the epidemiological space SARS-CoV-2 needs to evolve vaccine resistance. One Sentence SummaryModes of governance and production help set the evolutionary trajectories of vaccine resistance in SARS-CoV-2 before vaccine campaigns begin.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Assessing COVID-19 vaccination strategies in varied demographics using an individual-based model 92%
- Projecting the impact of SARS-CoV-2 variants on the COVID-19 epidemic and social restoration in the United States: a mathematical modelling study 90%
- Elevated blood glucose levels as a primary risk factor for the severity of COVID-19 90%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.